Pharmaceuticals

Fighting Diseases

Latest News
September 20, 2022
Not intended for U.S. and UK Media - EASD Congress 2022:
Bayer to present new cardiorenal data for Kerendia™ (finerenone) across a broad range of patients with early to late-stage chronic kidney disease and type 2 diabetes
September 11, 2022
Not intended for U.S. and UK Media – ESMO Congress 2022
New ARASENS data reinforce strong tolerability profile of darolutamide plus ADT and docetaxel without compromising quality of life for patients with mHSPC
September 08, 2022
Not intended for U.S. and UK Media
Aflibercept 8 mg first to achieve extended injection intervals of 16 weeks in up to 89% of patients